Your browser doesn't support javascript.
loading
Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin.
Li, Rifei; Zhu, Xinjie; Zhou, Peng; Qiao, Yuehua; Li, Yinqian; Xu, Yice; Shi, Xi.
Afiliação
  • Li R; College of Veterinary Medicine, Northwest A&F University, Yangling, China.
  • Zhu X; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, China.
  • Zhou P; Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
  • Qiao Y; Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
  • Li Y; Artificial Auditory Laboratory of Jiangsu Province, Xuzhou Medical University, Xuzhou, China.
  • Xu Y; College of Veterinary Medicine, Northwest A&F University, Yangling, China.
  • Shi X; Department of Otolaryngology-Head and Neck Surgery, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, China.
Front Immunol ; 13: 852700, 2022.
Article em En | MEDLINE | ID: mdl-35603157
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Neoplasias Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único / Neoplasias Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China